AMERICAN CENTURY COMPANIES INC – Vertex Pharmaceuticals Incorporated Transaction History
AMERICAN CENTURY COMPANIES INC portfolio value:
$364.84M
portfolio value
AMERICAN CENTURY COMPANIES INC quarter portfolio value change:
+2.75%
quarter
Vertex Pharmaceuticals Incorporated 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +6.83% | 80.56K shares | 32.46M | $289.54 | 1.26M |
| Q2 2022 | share | Increase | +7.15% | 78.65K shares | 45.08M | $281.79 | 1.17M |
| Q1 2022 | share | Increase | +76.29% | 476.42K shares | 150.16M | $260.97 | 1.10M |
| Q4 2021 | share | Decrease | -18.85% | -145.05K shares | -2.45M | $222.45 | 624.45K |
| Q3 2021 | share | Decrease | -14.52% | -130.75K shares | -41.93M | $181.39 | 769.50K |
| Q2 2021 | share | Increase | +25.53% | 183.07K shares | 27.40M | $201.63 | 900.26K |
| Q1 2021 | share | Decrease | -23.03% | -214.64K shares | -66.11M | $214.89 | 717.18K |
| Q4 2020 | share | Decrease | -9.37% | -96.33K shares | -59.55M | $236.34 | 931.83K |
| Q3 2020 | share | Increase | +26.42% | 214.85K shares | 43.67M | $272.12 | 1.02M |
| Q2 2020 | share | Decrease | -26.01% | -285.92K shares | -25.45M | $290.31 | 813.31K |
| Q1 2020 | share | Decrease | -2.36% | -26.62K shares | 15.05M | $237.95 | 1.09M |
| Q4 2019 | share | Increase | +13.74% | 135.98K shares | 78.80M | $218.95 | 1.12M |
| Q3 2019 | share | Increase | +7.46% | 68.70K shares | -1.22M | $169.42 | 989.87K |
| Q2 2019 | share | Increase | +1.22% | 11.06K shares | 1.51M | $183.38 | 921.17K |
| Q1 2019 | share | Decrease | -5.15% | -49.44K shares | 8.40M | $183.95 | 910.10K |
| Q4 2018 | share | Decrease | -16.45% | -188.86K shares | -62.33M | $165.71 | 959.55K |
| Q3 2018 | share | Increase | +2.04% | 22.99K shares | 30.06M | $192.74 | 1.14M |
| Q2 2018 | share | Increase | +357.46% | 879.41K shares | 151.18M | $169.96 | 1.12M |
| Q1 2018 | share | Increase | +38.13% | 67.91K shares | 13.40M | $162.98 | 246.01K |
| Q4 2017 | share | Increase | +8.90% | 14.56K shares | 1.82M | $149.86 | 178.10K |
| Q3 2017 | share | Decrease | -27.10% | -60.80K shares | -4.04M | $152.04 | 163.54K |
| Q2 2017 | share | Increase | +39.78% | 63.85K shares | 11.36M | $128.87 | 224.35K |
| Q1 2017 | share | Decrease | -44.65% | -129.47K shares | -3.81M | $109.35 | 160.49K |
| Q4 2016 | share | Decrease | -60.42% | -442.62K shares | -42.52M | $73.67 | 289.97K |
| Q3 2016 | share | Decrease | -44.41% | -585.25K shares | -49.47M | $87.21 | 732.60K |
| Q2 2016 | share | Decrease | -24.95% | -438.16K shares | -26.22M | $86.02 | 1.31M |
| Q1 2016 | share | Increase | +16.25% | 245.47K shares | -50.48M | $79.49 | 1.75M |